Medicare’s blame game
A Stanford researcher and his colleague got access to data showing the inner workings of an influential committee advising Medicare. They found that bias among its members has different effects from what critics claim.
Exome sequencing program launched
The Clinical Genomics Program, which began as a pilot program a few years ago, offers whole-exome sequencing and analysis to patients with undiagnosed genetic diseases.
Faculty join clinician-researcher honor society
Four Stanford Medicine clinician-researchers were elected to the medical honor society.
Protein clumps affect neural stem cells
Young, resting neural stem cells have large protein clumps often associated with neurodegeneration. As stem cells age, the aggregates inhibit their ability to make new neurons, Stanford researchers say.
Ethics review needed for AI use in health care
In a perspective piece, Stanford researchers discuss the ethical implications of using machine-learning tools in making health care decisions for patients.
Symposium to tackle AI balance in medicine
The Presence Center is hosting a daylong symposium April 17 on issues surrounding humans and machines in medicine.
Neuroanatomy lab bridges virtual reality, OR
Stanford’s Department of Neurosurgery has a new anatomy lab next door to its virtual reality center. Together, the labs are a valuable resource for trainees and surgeons alike.
Grants announced to investigate IBD
Eight Stanford Medicine researchers have received grants from the Kenneth Rainin Foundation to investigate inflammatory bowel disease.
Predicting success of lung cancer drug
With the help of a new radioactive tracer, doctors can predict with more than 80 percent accuracy how well a widely-used lung cancer drug will combat tumors, according to researchers at Stanford.
Misbehaving cells predict relapse in leukemia
Analyzing individual cancer cells has enabled Stanford researchers to identify the small population of cells that spur relapse in some children with leukemia.
CRISPR helps reveal drug targets for ALS
Through genome editing, scientists at Stanford have pinpointed genes that reveal mechanistic details of ALS and may even protect against the degeneration of neurons.
Reducing side effects of a cancer therapy
Stanford scientists created an odd couple: a modified version of an immune-signaling protein and a coordinately modified receptor for this protein. The two bind only to each other, easing an advanced anti-cancer therapy’s side effects.
Leading in Precision Health
Stanford Medicine is leading the biomedical revolution in precision health, defining and developing the next generation of care that is proactive, predictive and precise.
A Legacy of Innovation
Stanford Medicine's unrivaled atmosphere of breakthrough thinking and interdisciplinary collaboration has fueled a long history of achievements.